ESG Report 2019

3 ABOUT THE GROUP INTRODUCTION OF THE GROUP CONCEPT AND VISION Talents are the primary productive force of an enterprise. The Group emphasizes high-quality The Group is a comprehensive and modernized workforce construction, continuously improves pharmaceutical enterprise engaging in the research human resource management, establishes and and development, production and operation of improves our talent training, selection and cultivation intermediate products, bulk medicines and finished mechanism, and has gradually formed a “Friendly, products. The Group currently has six major Responsible, Hardworking and Highly-Efficient” production sites, namely The United Laboratories workforce. We always adhere to the philosophy of (Hong Kong) Co., Ltd., Zhuhai United Laboratories “Making Life More Valuable” to promote the Co., Ltd. (“Zhuhai Company”), Zhuhai United development of environmental protection and the Laboratories (Zhongshan) Co. (“Zhongshan charity sector with a high sense of social Company”), Guangdong Kaiping Kingly Capsule Co., responsibility. As for environmental protection, we Ltd., The United Laboratories (Inner Mongolia) Co., have made huge investment in creating a green Ltd. (“Inner Mongolia Company”), and The United enterprise. We actively support charities in multiple Animal Healthcare (Inner Mongolia) Co., Ltd. (“The fields such as education, disaster relief and social United Animal Healthcare”), with a total of welfare. Our efforts have been recognized by all approximately 13,000 employees. walks of society, which reflected our responsibilities and missions as a modern enterprise. In the future, the Group will continue to dedicate its Since its establishment, the Group has been efforts to the creation of an outstanding national dedicating to the production of high-quality pharmaceutical brand, promote the development of pharmaceuticals. All our factories have passed the the national medical and healthcare industry, and certification of China Good Manufacturing Practice create more high-quality and highly effective (“GMP”), and multiple products have obtained official pharmaceuticals. certifications such as the Certification of Suitability to the Monographs of the European Pharmacopoeia Organization and the US Food and Drug Administration (“FDA”). We adhere to independent innovations and possess strong research and development capabilities. Our products cover multiple fields including antibacterial drugs, diabetes drugs, nervous system drugs, ophthalmology drugs, t o p i c a l d e r m a t o l o g y d r u g s a n d o t h e r pharmaceuticals. Many scientific and technological achievements of the Group have obtained national patents. Environmental, Social and Governance Report 2019 The United Laboratories International Holdings Limited